INNOVIVA, INC. Increase (Decrease) in Other Noncurrent Assets
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Other Noncurrent Assets of $3.62 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-11-09
- INNOVIVA, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-09-30 was $2.78M.
- INNOVIVA, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-09-30 was $0.00.
- INNOVIVA, INC. increase (decrease) in other noncurrent assets for fiscal 2012 was $441.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2022-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.62M 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $844.00K 10-Q · filed 2022-07-27 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-07-27 | |||
| 2012-12-31 | $441.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |